SEARCH

SEARCH BY CITATION

References

  • Ahn K. W., Joo Y., Choi Y., Kim M., Lee S. H., Cha S. H., Suh Y. H. and Kim H. S. (2008) Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo. J. Neurosci. Res. 86, 24762487.
  • Alves da Costa C., Sunyach C., Pardossi-Piquard R. et al. (2006) Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer’s disease. J. Neurosci. 26, 63776385.
  • Anders L., Mertins P., Lammich S., Murgia M., Hartmann D., Saftig P., Haass C. and Ullrich A. (2006) Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin’s transcriptional activity. Mol. Cell. Biol. 26, 39173934.
  • Andersson C. X., Fernandez-Rodriguez J., Laos S., Baeckstrom D., Haass C. and Hansson G. C. (2005) Shedding and gamma-secretase-mediated intramembrane proteolysis of the mucin-type molecule CD43. Biochem. J. 387, 377384.
  • Araki Y., Miyagi N., Kato N. et al. (2004) Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation. J. Biol. Chem. 279, 2434324354.
  • Armogida M., Petit A., Vincent B., Scarzello S., da Costa C. A. and Checler F. (2001) Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts. Nat. Cell Biol. 3, 10301033.
  • Artavanis-Tsakonas S., Matsuno K. and Fortini M. E. (1995) Notch signaling. Science 268, 225232.
  • Baek S. H., Ohgi K. A., Rose D. W., Koo E. H., Glass C. K. and Rosenfeld M. G. (2002) Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell 110, 5567.
  • Bao J., Wolpowitz D., Role L. W. and Talmage D. A. (2003) Back signaling by the Nrg-1 intracellular domain. J. Cell Biol. 161, 11331141.
  • Bao J., Cao C., Zhang X., Jiang F., Nicosia S. V. and Bai W. (2007) Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol. Cell. Biol. 27, 13211333.
  • Bauer C., Pardossi-Piquard R., Dunys J., Roy M. and Checler F. (2011) g-Secretase-mediated regulation of neprilysin: influence of cell density, and aging and modulaton by imatinib. J. Alzheimers Dis. (in press).
  • Beel A. J. and Sanders C. R. (2008) Substrate specificity of gamma-secretase and other intramembrane proteases. Cell. Mol. Life Sci. 65, 13111334.
  • Belyaev N. D., Nalivaeva N. N., Makova N. Z. and Turner A. J. (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 10, 94100.
  • Belyaev N. D., Kellett K. A., Beckett C., Makova N. Z., Revett T. J., Nalivaeva N. N., Hooper N. M. and Turner A. J. (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway. J. Biol. Chem. 285, 4144341454.
  • Biederer T., Cao X., Sudhof T. C. and Liu X. (2002) Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms. J. Neurosci. 22, 73407351.
  • Blair C. R., Stone J. B. and Wells R. G. (2011) The type III TGF-beta receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease gamma-secretase. Biochim. Biophys. Acta 1813, 332339.
  • Bland C. E., Kimberly P. and Rand M. D. (2003) Notch-induced proteolysis and nuclear localization of the Delta ligand. J. Biol. Chem. 278, 1360713610.
  • Bloch L., Sineshchekova O., Reichenbach D., Reiss K., Saftig P., Kuro-o M. and Kaether C. (2009) Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett. 583, 32213224.
  • Bohm C., Seibel N. M., Henkel B., Steiner H., Haass C. and Hampe W. (2006) SorLA signaling by regulated intramembrane proteolysis. J. Biol. Chem. 281, 1454714553.
  • Borg J. P., Ooi J., Levy E. and Margolis B. (1996) The phosphotyrosine interaction domain of X11 and Fe65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol. Cell. Biol. 16, 62296241.
  • Bot N., Schweizer C., Ben Halima S. and Fraering P. C. (2010) Processing of the synaptic cell adhesion molecule neurexin-3beta by Alzheimer disease alpha- and gamma-secretases. J. Biol. Chem. 286, 27622773.
  • Bray S. J. (2006) Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678689.
  • Bressler S. L., Gray M. D., Sopher B. L. et al. (1996) cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum. Mol. Genet. 5, 15891598.
  • Brown M. S., Ye J., Rawson R. B. and Goldstein J. L. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391398.
  • Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C. and Glabe C. (1992) Assembly and aggregation properties of synthetic Alzheimer’s A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546554.
  • Caccamo A., Oddo S., Sugarman M. C., Akbari Y. and LaFerla F. M. (2005) Age- and region- dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders. Neurobiol. Aging 26, 645654.
  • Cai J., Jiang W. G., Grant M. B. and Boulton M. (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J. Biol. Chem. 281, 36043613.
  • Cai Y., Xiong K., Zhang X. M. et al. (2010) beta-Secretase-1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and beta-amyloid accumulation. Eur. J. Neurosci. 32, 12231238.
  • Cao X. and Südhof T. C. (2001) A transcriptively active complex of APP with Fe65 and histone acetyltransferase tip60. Science 293, 115120.
  • Carey B. W., Kim D. Y. and Kovacs D. M. (2007) Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins. Biochem. J. 401, 121127.
  • Chang K. A. and Suh Y. H. (2010) Possible roles of amyloid intracellular domain of amyloid precursor protein. BMB Rep. 43, 656663.
  • Chang K.-A., Kim H.-S., Ha T.-Y. et al. (2006) Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain, and induces neurodegeneration. Mol. Cell. Biol. 26, 43274338.
  • Checler F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer’s disease. J. Neurochem. 65, 14311444.
  • Checler F. (2001) The multiple paradoxes of presenilins. J. Neurochem. 76, 16211627.
  • Checler F., Sunyach C., Pardossi-Piquard R., Sevalle J., Vincent B., Kawarai T., Girardot N., St George-Hyslop P. and da Costa C. A. (2007) The gamma/epsilon-secretase-derived APP intracellular domain fragments regulate p53. Curr. Alzheimer Res. 4, 423426.
  • Checler F., Dunys J., Pardossi-Piquard R. and Alves da Costa C. (2010) p53 is regulated by and regulates members of the gamma-secretase complex. Neurodegener. Dis. 7, 5055.
  • Chen A. C. and Selkoe D. J. (2007) Response to: Pardossi-Piquard et al., “Presenilin-Dependent Transcriptional Control of the Abeta-Degrading Enzyme Neprilysin by Intracellular Domains of betaAPP and APLP”. Neuron 46, 541-554. Neuron 53, 479483.
  • Chen F., Gu Y., Hasegawa H., Ruan X., Arawaka S., Fraser P., Westaway D., Mount H. and St George-Hyslop P. (2002) Presenilin 1 mutations activate γ-42-secretase but reciprocally inhibit μ-secretase cleavage of APP and S3-cleavage of Notch. J. Biol. Chem. 277, 3652136526.
  • Chen F., Hasegawa H., Schmitt-Ulms G. et al. (2006) TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 440, 12081212.
  • Citron M., Vigo-Pelfrey C., Teplow D. B. et al. (1994) Excessive production of amyloid -protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc. Natl Acad. Sci. USA 91, 1199311997.
  • Cowan J. W., Wang X., Guan R., He K., Jiang J., Baumann G., Black R. A., Wolfe M. S. and Frank S. J. (2005) Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage. J. Biol. Chem. 280, 1933119342.
  • Duilio A., Faraonio R., Minopoli G., Zambrano N. and Russo T. (1998) Fe65L2: a new member of the Fe65 protein family interacting with the intracellular domain of the Alzheimer’s beta-amyloid precursor protein. Biochem. J. 330 (Pt 1), 513519.
  • Dumanchin-Njock C., Alves da Costa C. A., Mercken L., Pradier L. and Checler F. (2001) The caspase-derived C-terminal fragment of betaAPP induces caspase-independent toxicity and triggers selective increase of Abeta42 in mammalian cells. J. Neurochem. 78, 11531161.
  • Dunys J., Sevalle J., Giaime E. et al. (2009) p53-dependent control of transactivation of the Pen2 promoter by presenilins. J. Cell Sci. 122, 40034008.
  • Duyckaerts C., Delatour B. and Potier M. C. (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118, 536.
  • Edbauer D., Willem M., Lammich S., Steiner H. and Haass C. (2002) Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J. Biol. Chem. 277, 1338913393.
  • Eisele Y. S., Baumann M., Klebl B., Nordhammer C., Jucker M. and Kilger E. (2007) Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin. Mol. Biol. Cell 18, 35913600.
  • El Fiky A., Arch A. E. and Krolewski J. J. (2005) Intracellular domain of the IFNaR2 interferon receptor subunit mediates transcription via Stat2. J. Cell. Physiol. 204, 567573.
  • El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C. and Loike J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716719.
  • Elzinga B. M., Twomey C., Powell J. C., Harte F. and McCarthy J. V. (2009) Interleukin-1 receptor type 1 is a substrate for gamma-secretase-dependent regulated intramembrane proteolysis. J. Biol. Chem. 284, 13941409.
  • Esler W. P., Das C., Campbell W. A. et al. (2002) Amyloid-lowering isocoumarins are not direct inhibitors of gamma-secretase. Nat. Cell Biol. 4, E110E111; author reply E111–E112.
  • Farris W., Mansourian S., Chang Y. et al. (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA 100, 41624167.
  • Fiore F., Zambrano N., Minopoli G., Donini V., Duilo A. and Russo T. (1995) The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer’s disease amyloid precursor protein. J. Biol. Chem. 270, 3085330856.
  • Foveau B., Ancot F., Leroy C., Petrelli A., Reiss K., Vingtdeux V., Giordano S., Fafeur V. and Tulasne D. (2009) Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis. Mol. Biol. Cell 20, 24952507.
  • Fukumori A., Okochi M., Tagami S. et al. (2006) Presenilin-dependent gamma-secretase on plasma membrane and endosomes is functionally distinct. Biochemistry 45, 49074914.
  • Funamoto S., Morishima-Kawashima M., Tanimura Y., Hirotani N., Saido T. C. and Ihara M. (2004) Truncated carboxyl-terminal fragments of β-amyloid precursor protein are processed to amyloid β-proteins 40 and 42. Biochemistry 43, 1353213540.
  • Gandy S. (2005) The role of cerebral amyloid β accumulation in common forms of Alzheimer’s disease. J. Clin. Invest. 115, 11211129.
  • Gao Y. and Pimplikar S. W. (2001) The γ-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc. Natl Acad. Sci. USA 98, 1497914984.
  • Georgakopoulos A., Litterst C., Ghersi E., Baki L., Xu C., Serban G. and Robakis N. K. (2006) Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J. 25, 12421252.
  • Ghosal K., Vogt D. L., Liang M., Shen Y., Lamb B. T. and Pimplikar S. W. (2009) Alzheimer’s disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc. Natl Acad. Sci. USA 106, 1836718372.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. BBRC 120(3), 885890.
  • Goodger Z. V., Rajendran L., Trutzel A., Kohli B. M., Nitsch R. M. and Konietzko U. (2009) Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J. Cell Sci. 122, 37033714.
  • Gowrishankar K., Zeidler M. G. and Vincenz C. (2004) Release of a membrane-bound death domain by gamma-secretase processing of the p75NTR homolog NRADD. J. Cell Sci. 117, 40994111.
  • Gu Y., Misonou H., Sato T., Dohmae N., Takio K. and Ihara Y. (2001) Distinct intramembrane cleavages of the β-amyloid precursor protein family resembling γ-secretase-like cleavage of Notch. J. Biol. Chem. 276, 3523535238.
  • Guénette S. Y., Chen J., Jondro P. D. and Tanzi R. E. (1996) Association of a novel human FE65-like protein with the cytoplasmic domain of the β-amyloid precursor protein. Proc. Natl Acad. Sci. USA 93, 1083210837.
  • Gunawardena S. and Goldstein L. S. (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32, 389401.
  • Ha S., Furukawa R. and Fechheimer M. (2010a) Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis. Neurobiol. Aging (in press).
  • Ha T. Y., Chang K. A., Kim J., Kim H. S., Kim S., Chong Y. H. and Suh Y. H. (2010b) S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS ONE 5, e8840.
  • Haapasalo A. and Kovacs D. M. (2011) The many substrates of presenilin/gamma-secretase. J. Alzheimers Dis. 25, 328.
  • Haapasalo A., Kim D. Y., Carey B. W., Turunen M. K., Pettingell W. H. and Kovacs D. M. (2007) Presenilin/gamma-secretase-mediated cleavage regulates association of leukocyte-common antigen-related (LAR) receptor tyrosine phosphatase with beta-catenin. J. Biol. Chem. 282, 90639072.
  • Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L. and Selkoe D. (1995) The Swedish mutation causes early-onset Alzheimer’s disease by β-secretase cleavage within the secretory pathway. Nat. Med. 1, 12911296.
  • Hambsch B., Grinevich V., Seeburg P. H. and Schwarz M. K. (2005) {gamma}-Protocadherins, presenilin-mediated release of C-terminal fragment promotes locus expression. J. Biol. Chem. 280, 1588815897.
  • Hamid R., Kilger E., Willem M. et al. (2007) Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content. J. Neurochem. 102, 12641275.
  • Hardy J. A. and Higgins G. A. (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256, 184185.
  • Hass M. R. and Yankner B. A. (2005) A γ-secretase-independent mechanism of signal transduction by the amyloid precursor protein. J. Biol. Chem 280, 3689536904.
  • He G., Luo W., Li P. et al. (2010) Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease. Nature 467, 9598.
  • Hecimovic S., Wang J., Dolios G., Martinez M., Wang R. and Goate A. M. (2004) Mutations in APP have independent effects on Abeta and CTFgamma generation. Neurobiol. Dis. 17, 205218.
  • Hemming M. L., Elias J. E., Gygi S. P. and Selkoe D. J. (2008) Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. PLoS Biol. 6, e257.
  • Hermey G., Sjogaard S. S., Petersen C. M., Nykjaer A. and Gliemann J. (2006) Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members. Biochem. J. 395, 285293.
  • Hoe H. S. and Rebeck G. W. (2005) Regulation of ApoE receptor proteolysis by ligand binding. Brain Res. Mol. Brain Res. 137, 3139.
  • Hong Y., Beckett C., Belyaev N. D. and Turner A. J. (2011) The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells. Int. J. Cancer (in press).
  • Huysseune S., Kienlen-Campard P. and Octave J. N. (2007) Fe65 does not stabilize AICD during activation of transcription in a luciferase assay. Biochem. Biophys. Res. Commun. 361, 317322.
  • Huysseune S., Kienlen-Campard P., Hebert S., Tasiaux B., Leroy K., Devuyst O., Brion J. P., De Strooper B. and Octave J. N. (2009) Epigenetic control of aquaporin 1 expression by the amyloid precursor protein. FASEB J. 23, 41584167.
  • Hwang D. Y., Cho J. S., Kim C. K., Shim S. B., Jee S. W., Lee S. H., Seo S. J., Cho J. Y. and Kim Y. K. (2005) Aging-related correlation of insulin-degrading enzyme with gamma-secretase-generated products involving insulin and glucose levels in transgenic mice. Neurochem. Res. 30, 11711177.
  • Ikeuchi T. and Sisodia S. S. (2003) The Notch ligands, Delta 1 and Jagged 2 are substrates for presenilin-dependent “γ-secretase” cleavage. J. Biol. Chem. 278, 77517754.
  • Inoue E., Deguchi-Tawarada M., Togawa A. et al. (2009) Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation. J. Cell Biol. 185, 551564.
  • Iwatsubo T., Saido T. C., Mann D. M., Lee V. M.-Y. and Trojanowski J. Q. (1996) Full-length amyloid-β(1-42(43)) and amino-terminally modified and truncated amyloid-β42(43) deposit in diffuse plaques. Am. J. Pathol. 149, 18231830.
  • Kaimori J. Y., Nagasawa Y., Menezes L. F., Garcia-Gonzalez M. A., Deng J., Imai E., Onuchic L. F., Guay-Woodford L. M. and Germino G. G. (2007) Polyductin undergoes notch-like processing and regulated release from primary cilia. Hum. Mol. Genet. 16, 942956.
  • Kakuda N., Funamoto S., Yagishita S., Takami M., Osawa S., Dohmae N. and Ihara Y. (2006) Equimolar production of amyloid b protein and APP intracellular domain from β-carboxyl terminal fragment by γ-secretase. J. Biol. Chem. 281, 1477614786.
  • Kanning K. C., Hudson M., Amieux P. S., Wiley J. C., Bothwell M. and Schecterson L. C. (2003) Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability. J. Neurosci. 23, 54255436.
  • Kasuga K., Kaneko H., Nishizawa M., Onodera O. and Ikeuchi T. (2007) Generation of intracellular domain of insulin receptor tyrosine kinase by gamma-secretase. Biochem. Biophys. Res. Commun. 360, 9096.
  • Kim D. Y., Ingano L. A. and Kovacs D. M. (2002) Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage. J. Biol. Chem. 277, 4997649981.
  • Kim H.-S., Kim E.-M., Lee J.-P. et al. (2003) C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression. FASEB J. 17, 19511953.
  • Kim D. Y., Ingano L. A., Carey B. W., Pettingell W. H. and Kovacs D. M. (2005) Presenilin/gamma-secretase-mediated cleavage of the voltage-gated sodium channel beta2-subunit regulates cell adhesion and migration. J. Biol. Chem. 280, 2325123261.
  • Kimberly W. T., Zheng J. B., Guénette S. and Selkoe D. J. (2001) The intracellular domain of the b-amyloid precursor protein is stabilized by fe65 and translocates to the nucleus in a Notch-like manner. J. Biol. Chem. 276, 4028840292.
  • Kinoshita A., Whelan C. M., Berezovska O. and Hyman B. T. (2002) The γ-secretase-generated carboxy-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J. Biol. Chem. 277, 2853028536.
  • Kinoshita A., Shah T., Tangredi M. M., Strickland D. K. and Hyman B. T. (2003) The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J. Biol. Chem. 278, 4118241188.
  • Kogel D., Concannon C. G., Muller T., Konig H., Bonner C., Poeschel S., Chang S., Egensperger R. and Prehn J. H. (2011) The APP intracellular domain (AICD) potentiates ER stress-induced apoptosis. Neurobiol. Aging (in press).
  • Konietzko U., Goodger Z. V., Meyer M., Kohli B. M., Bosset J., Lahiri D. K. and Nitsch R. M. (2010) Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiol. Aging 31, 5873.
  • Kopan R. (2002) Notch: a membrane-bound transcription factor. J. Cell Sci. 115, 10951097.
  • Kopan R., Schroeter E. H., Weintraub H. and Nye J. S. (1996) Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc. Natl Acad. Sci. USA 93, 16831688.
  • Kuhn P. H., Marjaux E., Imhof A., De Strooper B., Haass C. and Lichtenthaler S. F. (2007) Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha -, beta -, and gamma -secretase. J. Biol. Chem. 282, 1198211995.
  • Kume H., Maruyama K. and Kametani F. (2004) Intracellular domain generation of amyloid precursor protein by ε-cleavage depends on C-terminal fragment by a-secretase cleavage. Int. J. Mol. Med. 13, 121125.
  • Kuperstein I., Broersen K., Benilova I. et al. (2010) Neurotoxicity of Alzheimer’s disease Abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio. EMBO J. 29, 34083420.
  • Lai M. T., Crouthamel M. C., DiMuzio J., Pietrak B. L., Donoviel D. B., Bernstein A., Gardell S. J., Li Y. M. and Hazuda D. (2006) A presenilin-independent aspartyl protease prefers the gamma-42 site cleavage. J. Neurochem. 96, 118125.
  • LaVoie M. J. and Selkoe D. J. (2003) The notch ligands jagged and delta, are sequentially processed by a-secretase and presenilin/g-secretase and release signaling fragments. J. Biol. Chem. 278, 3442734437.
  • Lewis B. A. and Reinberg D. (2003) The mediator coactivator complex: functional and physical roles in transcriptional regulation. J. Cell Sci. 116, 36673675.
  • Li Y., Cong R. and Biemesderfer D. (2008) The COOH terminus of megalin regulates gene expression in opossum kidney proximal tubule cells. Am. J. Physiol. Cell Physiol. 295, C529C537.
  • Litterst C., Georgakopoulos A., Shioi J., Ghersi E., Wisniewski T., Wang R., Ludwig A. and Robakis N. K. (2007) Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. J. Biol. Chem. 282, 1615516163.
  • Liu Q., Zerbinatti C. V., Zhang J., Hoe H. S., Wang B., Cole S. L., Herz J., Muglia L. and Bu G. (2007) Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56, 6678.
  • Lleo A. (2008) Activity of gamma-secretase on substrates other than APP. Curr. Top. Med. Chem. 8, 916.
  • Lu D. C., Rabizadeh S., Chandra S., Shayya R. F., Ellerby L. M., Ye X., Salvesen G. S., Koo E. H. and Bredesen D. E. (2000) A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat. Med. 6, 397404.
  • Marambaud P., Wen P. H., Dutt A., Shioi J., Takashima A., Siman R. and Robakis N. K. (2003) A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114, 635645.
  • Maretzky T., Schulte M., Ludwig A., Rose-John S., Blobel C., Hartmann D., Altevogt P., Saftig P. and Reiss K. (2005) L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol. Cell. Biol. 25, 90409053.
  • Marron M. B., Singh H., Tahir T. A., Kavumkal J., Kim H. Z., Koh G. Y. and Brindle N. P. (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J. Biol. Chem. 282, 3050930517.
  • Masters C. L., Simons G., Weinman N. A., Multhaup G., Mc Donald B. L. and Beyreuther K. (1985) Amyloid plaque core protein in Alzheimer’s Disease and Down Syndrome. Proc. Natl Acad. Sci. USA 82, 42454249.
  • May P., Reddy Y. K. and Herz J. (2002) Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277, 1873618743.
  • May P., Bock H. H., Nimpf J. and Herz J. (2003) Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. J. Biol. Chem. 278, 3738637392.
  • McElroy B., Powell J. C. and McCarthy J. V. (2007) The insulin-like growth factor 1 (IGF-1) receptor is a substrate for gamma-secretase-mediated intramembrane proteolysis. Biochem. Biophys. Res. Commun. 358, 11361141.
  • Mcloughlin D. M. and Miller C. C. J. (1996) The intracellular cytoplasmic domain of the Alzheimer’s disease amyloid precursor protein interacts with phosphotyrosine - binding domain proteins in the yeast two-hybrid system. FEBS Lett. 397, 197200.
  • Meyer E. L., Strutz N., Gahring L. C. and Rogers S. W. (2003) Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by gamma-secretase. J. Biol. Chem. 278, 2378623796.
  • Miller C. C., McLoughlin D. M., Lau K. F., Tennant M. E. and Rogelj B. (2006) The X11 proteins, Abeta production and Alzheimer’s disease. Trends Neurosci. 29, 280285.
  • Moehlmann T., Winkler E., Xia X. et al. (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc. Natl Acad. Sci. USA 99, 80258030.
  • Muller T., Concannon C. G., Ward M. W., Walsh C. M., Tirniceriu A. L., Tribl F., Kogel D., Prehn J. H. and Egensperger R. (2007) Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol. Biol. Cell 18, 201210.
  • Müller T., Meyer H. E., Egensperger R. and Marcus K. (2008) The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer’s disease. Prog. Neurobiol. 85, 393406.
  • Muresan Z. and Muresan V. (2004) A phosphorylated, carboxy-terminal fragment of {beta}-amyloid precursor protein localizes to the splicing factor compartment. Hum. Mol. Genet. 13, 475488.
  • Nakaya T. and Suzuki T. (2006) Role of APP phosphorylation in Fe65-dependent gene transactivation mediated by AICD. Genes Cells 11, 633645.
  • Nakayama K., Ohkawara T., Hiratochi M., Koh C. S. and Nagase H. (2008) The intracellular domain of amyloid precursor protein induces neuron-specific apoptosis. Neurosci. Lett. 444, 127131.
  • Netzer W. J., Dou F., Cai D. et al. (2003) Gleevec inhibits β-amyloid production but not Notch cleavage. Proc. Natl Acad. Sci. USA 100, 1244412449.
  • Ni C. Y., Murphy M. P., Golde T. E. and Carpenter G. (2001) gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294, 21792181.
  • Nistor M., Don M., Parekh M. et al. (2007) Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol. Aging 28, 14931506.
  • Niwa M., Sidrauski C., Kaufman R. J. and Walter P. (1999) A role for presenilin-1 in nuclear accumulation of Ire1 fragments and induction of the mammalian unfolded protein response. Cell 99, 691702.
  • Nunan J., Shearman M. S., Checler F., Cappai R., Evin G., Beyreuther K., Masters C. L. and Small D. H. (2001) The C-terminal fragment of the Alzheimer’s disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase. Eur. J. Biochem. 268, 53295336.
  • Nyborg A. C., Ladd T. B., Zwizinski C. W., Lah J. J. and Golde T. E. (2006) Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates. Mol. Neurodegener. 1, 3.
  • Ohkawara T., Nagase H., Koh C. S. and Nakayama K. (2011) The amyloid precursor protein intracellular domain alters gene expression and induces neuron-specific apoptosis. Gene 475, 19.
  • Ohyagi Y. (2008) Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer’s disease. Curr. Alzheimer Res. 5, 555561.
  • Ohyagi Y., Asahara H., Chui D. H. et al. (2005) Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer’s disease. FASEB J. 19, 255257.
  • Okamoto I., Kawano Y., Murakami D., Sasayama T., Araki N., Miki T., Wong A. J. and Saya H. (2001) Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J. Cell Biol. 155, 755762.
  • Olsen J. V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P. and Mann M. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635648.
  • Ozaki T., Li Y., Kikuchi H., Tomita T., Iwatsubo T. and Nakagawara A. (2006) The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis. Biochem. Biophys. Res. Commun. 351, 5763.
  • Pardossi-Piquard R., Petit A., Kawarai T. et al. (2005) Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46, 541554.
  • Pardossi-Piquard R., Dunys J., Yu G., St George-Hyslop P., Alves da Costa C. and Checler F. (2006) Neprilysin activity and expression are controlled by nicastrin. J. Neurochem. 97, 10521056.
  • Pardossi-Piquard R., Dunys J., Kawarai T. et al. (2007) Response to correspondence: Pardossi-Piquard et al., “Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betAAPP and APLP” Neuron 46, 541–554; Neuron 53, 483486.
  • Passer B., Pellegrini L., Russo C., Siegel R. M., Lenardio M. J., Schettini G., Bachmann M., Tabaton M. and D’Adamio L. (2000) Generation of an apoptotic intracellular peptide by γ-secretase cleavage of Alzheimer’s amyloid β protein precursor. J. Alzheimer’s Dis. 2, 289301.
  • Petit A., Bihel F., Alves da Costa C., Pourquie O., Checler F. and Kraus J. L. (2001) New protease inhibitors prevent gamma-secretase-mediated production of Abeta40/42 without affecting Notch cleavage. Nat. Cell Biol. 3, 507511.
  • Phiel C. J., Wilson C. A., Lee V. M.-Y. and Klein P. S. (2003) GSK-3α regulates production of Alzheimer’s disease amyloid-β peptides. Nature 423, 435439.
  • Pimplikar S. W. and Suryanarayana A. (2011) Detection of APP intracellular domain in brain tissue. Methods Mol. Biol. 670, 8591.
  • Qi-Takahara Y., Morishima-Kawashima M., Tanimura Y. et al. (2005) Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J. Neurosci. 25, 436445.
  • Rajagopal C., Stone K. L., Mains R. E. and Eipper B. A. (2010) Secretion stimulates intramembrane proteolysis of a secretory granule membrane enzyme. J. Biol. Chem. 285, 3463234642.
  • Rajendran L., Honsho M., Zahn T. R., Keller P., Geiger K. D., Verkade P. and Simons K. (2006) Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc. Natl Acad. Sci. USA 103, 1117211177.
  • Raychaudhuri M. and Mukhopadhyay D. (2007) AICD and its adaptors – in search of new players. J. Alzheimers Dis. 11, 343358.
  • Rogelj B., Mitchell J. C., Miller C. C. and McLoughlin D. M. (2006) The X11/Mint family of adaptor proteins. Brain Res. Rev. 52, 305315.
  • Roncarati R., Sestan N., Scheinfeld M. H., Berechid B. E., Lopez P. A., Meucci O., McGlade J. C., Rakic P. and D’Adamio L. (2002) The g-secretase-generated intracellular domain of b-amyloid precursor proptein binds Numb and inhibits Notch signaling. Proc. Natl Acad. Sci. USA 99, 71027107.
  • von Rotz R. C., Kohli B. M., Bosset J., Meier M., Suzuki T., Nitsch R. M. and Konietzko U. (2004) The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J. Cell Sci. 117, 44354448.
  • Ryan K. A. and Pimplikar S. W. (2005) Activation of GSK3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 171, 327335.
  • Saleh A. Z., Fang A. T., Arch A. E., Neupane D., El Fiky A. and Krolewski J. J. (2004) Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor. Oncogene 23, 70767086.
  • Sastre M., Steiner H., Fuchs K., Capell A., Multhaup G., Condron M. M., Teplow D. B. and Haass C. (2001) Presenilin dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2, 835841.
  • Sato T., Dohmae N., Qi Y. et al. (2003) Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein. J. Biol. Chem. 278, 2429424301.
  • Scheinfeld M. H., Ghersi E., Laky K., Fowlkes B. J. and D’Adamio L. (2002) Processing of β-amyloid precursor like protein-1 and -2 by γ-secretase regulates transcription. J. Biol. Chem. 277, 4419544201.
  • Scheinfeld M. H., Matsuda S. and D’adamio L. (2003) JNK-interacting protein-1 promotes transcription of ab protein precursor protein but not ab precursor-like proteins, mechanistically different than Fe65. Proc. Natl Acad. Sci. USA 100, 17291734.
  • Schrenk-Siemens K., Perez-Alcala S., Richter J., Lacroix E., Rahuel J., Korte M., Muller U., Barde Y. A. and Bibel M. (2008) Embryonic stem cell-derived neurons as a cellular system to study gene function: lack of amyloid precursor proteins APP and APLP2 leads to defective synaptic transmission. Stem Cells 26, 21532163.
  • Schulte A., Schulz B., Andrzejewski M. G. et al. (2007) Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases. Biochem. Biophys. Res. Commun. 358, 233240.
  • Schulz J. G., Annaert W., Vandekerckhove J., Zimmermann P., De Strooper B. and David G. (2003) Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling. J. Biol. Chem. 278, 4865148657.
  • Schulz B., Pruessmeyer J., Maretzky T., Ludwig A., Blobel C. P., Saftig P. and Reiss K. (2008) ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ. Res. 102, 11921201.
  • Selkoe D. J. (2001) Alzheimer’s disease: genes, proteins and therapy. Physiol. Rev. 81, 741766.
  • Sevalle J., Ayral E., Hernandez J. F., Martinez J. and Checler F. (2009) Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity. J. Neurochem. 110, 275283.
  • Six E., Ndiaye D., Laabi Y., Brou C., Gupta-Rossi N., Israel A. and Logeat F. (2003) The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc. Natl Acad. Sci. USA 100, 76387643.
  • Stoeck A., Shang L. and Dempsey P. J. (2010) Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth. J. Cell Sci. 123, 23192331.
  • Suh Y. H. and Checler F. (2002) Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s disease. Pharmacol. Rev. 54, 469525.
  • Takahashi K., Niidome T., Akaike A., Kihara T. and Sugimoto H. (2009) Amyloid precursor protein promotes endoplasmic reticulum stress-induced cell death via C/EBP homologous protein-mediated pathway. J. Neurochem. 109, 13241337.
  • Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., Thinakaran G. and Iwatsubo T. (2003) The role of presenilin cofactors in the γ-secretase complex. Nature 422, 438441.
  • Takeda A., Araki W., Akiyama H. and Tabira T. (2004) Amino-truncated amyloid β-peptide (Aβ5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer’s disease brain. FASEB J. 18, 17551757.
  • Taniguchi Y., Kim S. H. and Sisodia S. S. (2003) Presenilin-dependent “gamma-secretase” processing of deleted in colorectal cancer (DCC). J. Biol. Chem. 278, 3042530428.
  • Tanzi R. E. and Bertram L. (2001) New frontiers in Alzheimer’s disease genetics. Neuron 32, 181184.
  • Tekirian T. L., Yang A. Y., Glabe C. and Geddes J. W. (1999) Toxicity of pyroglutaminated amyloid β-peptides 3(pE)-40 and -42 is similar to that of Aβ1-40 and -42. J. Neurochem. 73, 15841589.
  • Thal D. R., Sassin I., Schultz C., Haass C., Braak E. and Braak H. (1999) Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta. J. Neuropathol. Exp. Neurol. 58, 210216.
  • Tomita T., Tanaka S., Morohashi Y. and Iwatsubo T. (2006) Presenilin-dependent intramembrane cleavage of ephrin-B1. Mol. Neurodegener. 1, 2.
  • Tousseyn T., Thathiah A., Jorissen E. et al. (2009) ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J. Biol. Chem. 284, 1173811747.
  • Trazzi S., Mitrugno V. M., Valli E., Fuchs C., Rizzi S., Guidi S., Perini G., Bartesaghi R. and Ciani E. (2011) APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. Hum. Mol. Genet. 20, 15601573.
  • Vassar R., Kovacs D. M., Yan R. and Wong P. C. (2009) The beta-secretase enzyme BACE in health and Alzheimer’s disease: regulation, cell biology, function, and therapeutic potential. J. Neurosci. 29, 1278712794.
  • Vazquez M. C., Vargas L. M., Inestrosa N. C. and Alvarez A. R. (2009) c-Abl modulates AICD dependent cellular responses: transcriptional induction and apoptosis. J. Cell. Physiol. 220, 136143.
  • Venugopal C., Pappolla M. A. and Sambamurti K. (2007) Insulysin cleaves the APP cytoplasmic fragment at multiple sites. Neurochem. Res. 32, 22252234.
  • Vingtdeux V., Hamdane M., Begard S., Loyens A., Delacourte A., Beauvillain J. C., Buee L., Marambaud P. and Sergeant N. (2007) Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiol. Dis. 25, 686696.
  • Vogt D. L., Thomas D., Galvan V., Bredesen D. E., Lamb B. T. and Pimplikar S. W. (2011) Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol. Aging 32, 17251729.
  • Walsh D. M. and Selkoe D. J. (2007) A beta oligomers – a decade of discovery. J. Neurochem. 101, 11721184.
  • Wang R., Tang P., Wang P., Boissy R. E. and Zheng H. (2006) Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer’s disease mutation. Proc. Natl Acad. Sci. USA 103, 353358.
  • Weggen S., Eriksen J. L., Das P. et al. (2001) A subset of NSAIDs lower amyloidogenic Ab42 independently of cyclooxygenase activity. Nature 414, 212216.
  • Weidemann A., Eggert S., Reinhard F. B. M., Vogel M., Paliga K., Baier G., Masters C. L., Beyreuther K. and Evin G. (2002) A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with the Notch processing. Biochemistry 41, 28252835.
  • Weihofen A. and Martoglio B. (2003) Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides. Trends Biochem. Sci. 13, 7178.
  • Wiley J. C., Smith E. A., Hudson M. P., Ladiges W. C. and Bothwell M. (2007) Fe65 stimulates proteolytic liberation of the beta-amyloid precursor protein intracellular domain. J. Biol. Chem. 282, 3331333325.
  • Wilhelmsen K. and van der Geer P. (2004) Phorbol 12-myristate 13-acetate-induced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage events. Mol. Cell. Biol. 24, 454464.
  • Wilson C. A., Doms R. W., Zheng H. and Lee V. M.-Y. (2002) Presenilins are not required for Aβ42 production in the early secretory pathway. Nat. Neurosci. 5, 849855.
  • Wilson C. A., Doms R. W. and Lee V. M.-Y. (2003) Distinct presenilin-dependent and presenilin-independent γ-secretases are responsible for total cellular Aβ production. J. Neurosci. Res. 74, 361369.
  • Wolfe M. S., Xia W., Moore C. L., Leatherwood D. D., Ostaszewski B., Rahmati T., Donkor I. O. and Selkoe D. J. (1999a) Peptidomimetic probes and molecular modeling suggest that Alzheimer’s gamma-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry 38, 47204727.
  • Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T. and Selkoe D. J. (1999b) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513517.
  • Wong H. K., Sakurai T., Oyama F. et al. (2005) beta Subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J. Biol. Chem. 280, 2300923017.
  • Xu Y., Kim H.-S., Yoo Y. et al. (2006) Intracellular domains of amyloid precursor-like protein 2 interacts with CP2 transcription factor in the nucleus and induce glycogen synthase kinase-3β expression. Cell Death Diff. 14, 7991.
  • Xu X., Zhou H. and Boyer T. G. (2011) Mediator is a transducer of amyloid-precursor-protein-dependent nuclear signalling. EMBO Rep. 12, 216222.
  • Yagishita S., Futai E. and Ishiura S. (2008) In vitro reconstitution of gamma-secretase activity using yeast microsomes. Biochem. Biophys. Res. Commun. 377, 141145.
  • Yan S. D., Chen X., Fu J. et al. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer’s disease. Nature 382, 685691.
  • Yu C., Kim S. H., Ikeuchi T., Xu H., Gasparini L., Wang R. and Sisodia S. S. (2001) Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notch1 transmembrane domains. J. Biol. Chem. 276, 4375643760.
  • Zambrano N., Minopoli G., de Candia P. and Russo T. (1998) The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J. Biol. Chem. 273, 2012820133.
  • Zhang C., Khandelwal P. J., Chakraborty R. et al. (2007) An AICD-based functional screen to identify APP metabolism regulators. Mol. Neurodegener. 2, 15.
  • Zhou D., Zambrano N., Russo T. and D’Adamio L. (2009) Phosphorylation of a tyrosine in the amyloid-beta protein precursor intracellular domain inhibits Fe65 binding and signaling. J. Alzheimers Dis. 16, 301307.
  • Zou Z., Chung B., Nguyen T., Mentone S., Thomson B. and Biemesderfer D. (2004) Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule. J. Biol. Chem. 279, 3430234310.